About this trial
The purpose of this project is to compare the performance and validity of novel wearable technologies that measure blood pressure (BP) and physical activity with a Spacelabs Ambulatory Blood Pressure Monitoring (ABPM) device.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age 18 to 100 years
All neighborhoods in Boston area
Be able to walk with two limbs and have two arms
Willing and able to complete required measurement procedures
Disqualifiers
Failure to receive informed consent
Arm circumference of more than 50cm
Trial design
Crossover
Treatments tested in this trial
ABPMPro
DeviceThis is an upper arm, cuff-based intermittent ambulatory BP device. This device has an internal activity and body position sensor which gathers information about sleep-wake estimation.
Spacelabs Ambulatory Blood Pressure Monitoring
DeviceThis is an upper arm cuff-based device with tubing for continuous ambulatory BP monitoring with a unique activity sensor that correlate with patient movement activity with blood pressure changes.
Aktiia Blood Pressure
DeviceThis is a wrist cuff-based device which uses an optical sensor (photoplethysmography sensor) to gather data from the arteries under the skin surface. Aktiia has an upper arm cuff device which is used for calibration once every month to provide a baseline blood pressure reading.
LiveMetric
DeviceThis is a wrist cuff-based applanation tonometry continuous ambulatory BP device. This device has automatic self-calibration and comes in various sizes.
Bpro
DeviceThis is a wrist cuff-based wireless oscillometric, continuous ambulatory BP device. It has applanation tonometry at the wrist with Pulse wave analysis. This device needs calibration with a brachial cuff BP measurement.
Treatment groups
Trial outcomes
Primary outcomes
Systolic Blood Pressure
Measured from all 5 randomized devices
Secondary outcomes
Diastolic Blood Pressure
Measured from all 5 randomized devices
Heart Rate
Measured from all 5 randomized devices
ActivPaL device (Physical activity monitor)
Physical activity intensity and type of activity will be characterized throughout the 48hr wear period. While the investigators are interested in the impact of devices on activity, the investigators are also interested in the relationship between activities and blood pressure.
Other outcomes
Systolic blood pressure from the Biobeat device (Chest Patch Blood Pressure device)
This is a continuous ambulatory BP device which is worn as a patch on the chest. This device needs calibration with a brachial cuff BP measurement. This will be typically worn on day 2. This is not a randomized assessment.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Stephen Juraschek
Lead sponsor
Beth Israel Deaconess Medical Center
Sponsor institution
National Institutes of Health (NIH)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator